Deletion of platelet CLEC-2 decreases GPIbα-mediated integrin αIIbβ3 activation and decreases thrombosis in TTP
Bojing Shao(Oklahoma Medical Research Foundation), Lijun Xia(Oklahoma Medical Research Foundation), Yuji Kondo(Frontier Science Foundation), Karen Vanhoorelbeke(Research Institute for Chromatography), Xindi Shan(Oklahoma Medical Research Foundation), Junmei Chen(National University of Singapore), Christopher Hoover(Oklahoma Medical Research Foundation), Jianhua Song(Oklahoma Medical Research Foundation), James N. George(University of Oklahoma Health Sciences Center), Meixiang Zhou(Oklahoma Medical Research Foundation), J. Michael McDaniel(Oklahoma Medical Research Foundation), Samuel McGee(Oklahoma Medical Research Foundation), Wolfgang Bergmeier(University of North Carolina at Chapel Hill), Robert H. Lee(University of North Carolina at Chapel Hill), José A. López(Bloodworks Northwest), Huiping Shi(Beijing Institute of Technology)
Cited by 21
Related Papers
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.
|Journal of Clinical Investigation|1986|448
Estrogen-related Receptor, hERR1, Modulates Estrogen Receptor-mediated Response of Human Lactoferrin Gene Promoter
|Journal of Biological Chemistry|1996|198
Improved quality of life for romiplostim‐treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo‐controlled trials
|British Journal of Haematology|2008|146